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Abstract
During inflammation polymorphonuclear neutrophils (PMNs) traverse venular walls, composed of the endothelium, pericyte
sheath and vascular basement membrane. Compared to PMN transendothelial migration, little is known about how PMNs
penetrate the latter barriers. Using mouse models and intravital microscopy, we show that migrating PMNs expand and use
the low expression regions (LERs) of matrix proteins in the vascular basement membrane (BM) for their transmigration.
Importantly, we demonstrate that this remodeling of LERs is accompanied by the opening of gaps between pericytes, a
response that depends on PMN engagement with pericytes. Exploring how PMNs modulate pericyte behavior, we
discovered that direct PMN-pericyte contacts induce relaxation rather than contraction of pericyte cytoskeletons, an
unexpected response that is mediated by inhibition of the RhoA/ROCK signaling pathway in pericytes. Taking our in vitro
results back into mouse models, we present evidence that pericyte relaxation contributes to the opening of the gaps
between pericytes and to the enlargement of the LERs in the vascular BM, facilitating PMN extravasation. Our study
demonstrates that pericytes can regulate PMN extravasation by controlling the size of pericyte gaps and thickness of LERs in
venular walls. This raises the possibility that pericytes may be targeted in therapies aimed at regulating inflammation.
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Introduction
Inflammation is a host defense response to infection or injury.
Triggered inappropriately, however, this reaction may induce
progressive tissue injury, a clinical phenomenon that is involved in
deterioration of inflammation-associated diseases such as progres-
sive expansion of posttraumatic wounds and secondary tissue
necrosis at sites of myocardial infarction [1,2]. In addition,
inappropriate inflammation underlies many inflammatory diseas-
es, from rheumatoid arthritis and inflammatory bowel disease to
asthma and multiple sclerosis. As key inflammatory cells,
polymorphonuclear neutrophils (PMNs) participate in these
pathological events by releasing bioactive products such as
neutrophil elastase and oxygen free radicals into sites of
inflammation [3], a process that requires circulating PMNs to be
recruited out of the circulation and across venular walls, i.e.
neutrophil extravasation. Migrating across venular walls, PMNs
have to traverse two cellular layers, crossing first the endothelium
and then the pericyte sheath, and their associated basement
membrane (BM) before moving into the interstitium [4].
Whereas much is known about how PMNs breach the
endothelium during extravasation, little is known about how
migrating PMNs traverse the pericyte sheath and vascular BM
[4,5,6]. However, migrating leukocytes tend to accumulate in the
space between the endothelium and vascular BM suggesting that
the latter presents a significant barrier to leukocyte transmigration
[7,8]. Regarding crossing the BM, it was previously shown by one
of us (S. Wang) that PMNs preferentially penetrate special areas
within the mouse cremaster vascular BM where matrix proteins
(e.g. laminins and collagen type IV) are distributed sparsely. These
regions, referred to as low expression regions (LERs), become
enlarged and thinner in a process of inflammation-induced
remodeling of the vascular BM [9]. The ubiquitous existence of
LERs and inflammation-induced remodeling of these sites was
further confirmed in multiple tissues by Voisin et al [10].
However, little is known about how remodeling of LERs occurs
during acute inflammation. In these previous studies, pericytes
were simply used as reference points to indicate the location of
LERs in venular walls. While they demonstrated that LERs align
with gaps between adjacent pericytes [9,10], these studies did not
address whether pericytes contribute to the remodeling of the
vascular BM at the LERs, or investigate whether pericytes play a
role in leukocyte transmigration.
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Unlike endothelial cells (ECs), which line the interior surface of
blood vessels as a continuous cell monolayer linked by cell-cell
junctions, pericytes are arranged in a sheath surrounding the
endothelium [4,9,11,12]. No specialized intercellular junctions
have been identified between pericytes [11]. Both ECs and
pericytes contribute to the formation of the vascular BM.
However, within venular walls, the EC monolayer contacts the
vascular BM with its abluminal surface, whereas the pericyte
sheath is embedded in this matrix [4,9,11,13]. The location of
pericytes and their morphology surrounding the endothelium,
coupled with their capacity to contract or relax, imply that
structural changes in the pericyte sheath may affect the
organization of the vascular BM during inflammation and
influence PMN transmigration.
Here we have examined the response of pericytes to PMNs in
IL-1b-stimulated venular walls in mouse cremaster muscles. Our
results demonstrate that during inflammation direct engagement
between migrating PMNs and pericytes induces expansion of
pericyte gaps and their associated LERs in the vascular BM,
thereby facilitating PMN passage across inflamed venular walls.
Exploring the engagement of activated PMNs with mouse primary
pericytes in culture reveals that PMNs induce pericyte relaxation
via inhibition of the RhoA/Rho Kinase (ROCK) pathway and
suppression of actomyosin-based contractility. Our study shows
that it is relaxation rather than contraction of pericytes that opens
the gaps between them to facilitate PMN extravasation.
Materials and Methods
Ethics Statement
All experiments were approved by the Institutional Animal Care
Committee of the University of North Carolina School of
Medicine and Public health and performed according to the
legislation for the protection of animals (IACUC ID: 12–038.0).
Experimental Animals
Wild type (WT) C57BL/6 mice were purchased from the
Jackson lab. Platelet-endothelial cell adhesion molecule–deficient
(PECAM-12/2) mice on a C57BL/6 background were kindly
provided by Dr P. Newman (Blood Research Institute, Blood
Center of Wisconsin, Milwaukee). C57BL/6 immorto-mice
expressing a SV40 large T antigen were obtained from Charles
River Laboratories (Wilmington, MA).
Inflammatory Response in Mouse Cremaster Muscles or
Ear Skin and Intravital Microscopy
WT or PECAM-12/2 male mice (,25 g) were injected
intrascrotally (i.s.) with saline, interleukin-1b (IL-1b) (50 ng/
mouse) or tumor necrosis factor-a (TNF-a) (500 ng/mouse)
(R&D Systems, Minneapolis, MN). In IL-1b-injected mouse
cremaster muscles, the responding leukocytes (.90%) were
previously verified to be PMNs [14]. In selected experiments
where PMNs need to be depleted, 100 mg of anti-GR1 antibodies
(Abs) [15] (RB6–8C5, BD Biosciences, Chicago, IL) were injected
intraperitoneally (i.p.) into each mouse 24 hours before i.s.
administration of IL-1b. To block PMN extravasation, in some
experiments each mouse was intra-splenically pre-injected with
100 mg of Abs against either mouse intercellular adhesion
molecule-1 (ICAM-1) (YN1/1.7.4, Biolegend, San Diego, CA)
[16] or a6 integrin (GoH3, Biolegend, San Diego, CA) [17,18] 15
minutes before IL-1b administration. Control animals received
isotype-matched control Abs (Biolegend, San Diego, CA). Two
hours after IL-1b injection, the cremaster muscles of fully
anaesthetized mice were exteriorized and transferred to the stage
of an Olympus FluoView FV1000 upright microscope and the
cremaster muscles were constantly superfused with warm buffered
solution. The numbers of rolling or static adherent leukocytes were
quantified starting from the administration of superfusion buffer as
described before [14]. In some experiments, cremaster muscles
were clamped using a micro aneurysm clip (Harvard Apparatus,
Holliston, MA) and superfused with buffer containing Norepi-
nephrine (NE, 10 mM, Sigma-Aldrich, Saint Louis, MO) or
Tolazoline (100 mg/ml, Sigma-Aldrich, Saint Louis, MO). Fifteen
min later, the inflammatory response was stopped immediately by
perfusion of 4% paraformaldehyde (PF). The cremaster muscles of
all experimental mice were finally harvested and fixed in PF for
further immunostaining. In some experiments, IL-1b (5 ng/
mouse) or TNF-a (50 ng/mouse) in 50 ml saline was subcutane-
ously injected into mouse ears for two hours to induce an
inflammatory response in skin.
Immunostaining of Mouse Cremaster Muscles and Ear
Skin
Fixed mouse cremaster muscles and ear skin were immuno-
stained for multiple proteins as described previously [9]. An Alexa
488- or 647-labeled rat anti-mouse PECAM-1 Ab (MEC13.3
BioLegend, San Diego, CA) was applied to label ECs. The
vascular BM was displayed by a rabbit anti–mouse collagen IV
polyclonal Ab (Abcam, Cambridge, MA) plus appropriate
secondary Abs conjugated to Alexa 405 or 488 (Invitrogen,
Carlsbad, CA). To mark the PMNs, a goat anti–mouse MRP-
14 Ab (Calgranulin B (M-19), Santa Cruz Biotechnology, Santa
Cruz, CA) or Allophycocyanin-conjugated rat anti-mouse CD11b
Ab (M1/70, eBioscience, San Diego, CA) was used. To stain the
pericytes, tissues were further incubated with a Cy3-labeled anti-
mouse a-SMA Ab (1A4, Sigma-Aldrich, St. Louis, MO) or a goat
IgG against mouse Platelet-derived growth factor receptor-b
(PDGFR-b) (R&D Systems, Minneapolis, MN) plus fluorescent
secondary Abs. In all studies, appropriate control IgG (BioLegend,
San Diego, CA) was used in parallel with the specific primary Abs.
Imaging and Analysis of Immunostained Cremaster
Muscles and Ear Skin
Immunostained samples were imaged in three-dimensions (3D)
using a Zeiss 510 Meta confocal microscope with lasers excited at
488, 545, 633, and 740 nm respectively, and with a x40 water-
dipping objective (numerical aperture = 1.25). The imaged tissues
were quantified for transmigrating leukocytes, defined as the
number of leukocytes within the immunostained venular walls (per
200 mm vessel segment) and extravasated leukocytes, defined as
the number of leukocytes in the interstitium of the whole tissues
(per mm2 cremaster muscle) or in the interstitial tissues within
100 mm around a 200 mm vessel segment. 3D images of vessels
were split in the middle along the longitudinal axis using the LSM
software and fluorescence intensity of ‘‘hemi-vessels’’ was ana-
lyzed. The area of gaps between adjacent pericytes, the area of
Collagen IV LERs, and the protein contents of Collagen IV in
LERs (fluorescence intensity, pixels/unit area), were measured as
previously described [9].
Isolation of Mouse Peritoneal PMNs
Mouse PMNs were harvested from the thioglycollate-stimulated
peritoneal cavity as previously described [19]. Briefly 1 ml of 4%
thioglycollate solution (Sigma-Aldrich, St. Louis, MO) was injected
into the mouse peritoneal cavity. Four hours later, exudate cells
were harvested and purified for PMNs by Percoll density gradient
centrifugation, yielding PMN preparations of around 90% purity.
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Collection of Mouse Bone Marrow PMNs and Culture of
Mouse Retinal Pericytes
Bone marrow neutrophils were harvested from wash-outs of
femurs of mice using three-layer Percoll gradients, yielding
neutrophil preparations of around 85% purity [20]. Primary
pericytes were isolated from retinas of WT Immorto mice (6–7
pups, 4 week old). Twelve to fourteen retinas were collected and
digested at 37uC for 45 min in serum-free DMEM containing
collagenase type II (1 mg/ml, Worthington, Lakewood, NJ) and
0.1% BSA. After washes, digested tissue was resuspended in
DMEM supplied with 10% FBS, 2 mM L-glutamine, 100 g/ml
streptomycin, 100 U/ml penicillin, and murine recombinant
interferon-c (at 44 U/ml, R&D Systems, Minneapolis, MN) and
cultured at 33uC with 5% CO2. Cells were progressively passed to
larger plates [21] and used for different assays within 20 passages.
Collection of Transmigrated PMNs in vitro
Within a 6-well Boyden transwell, mouse primary retinal
endothelial cells were seeded on the top surface of each FN-pre-
coated insert (with 3 mm pores) and grown to confluence. Then the
endothelial cell layer was incubated with serum-free DMEM
containing TNF-a (10 ng/ml) overnight and freshly isolated
mouse bone marrow PMNs were added on the top of the
endothelial cells. The inserts were put back into the wells
containing serum-free DMEM in the presence of 3.061028 M
of interleukin-8 (IL-8, R&D Systems, Minneapolis, MN) and
incubated at 37uC for 4 hours. Transmigrated PMNs were
harvested and washed for further experiments.
Retroviral Packing and Infection
Retroviral packaging and infection were performed as previ-
ously described [22]. Briefly, human 293 FT cells (Invitrogen,
Carlsbad, CA) were placed on poly (L-Lysine)-pre-coated dish and
transfected with the packing plasmids pRSV-Rev, pMDLg/
pRRE, pCMV-VSV-G (Addgene, Cambridge, MA) and the
pLentiLox 5.0 shuttle plasmid encoding WT, constitutively active
(CA) Q63L, or dominant negative (DN) T19N human RhoA.
Virus-containing medium, together with 6 mg/ml of polybrene,
was added to pericytes which were plated at 50% confluence.
Forty eight hours later, protein expression was checked by using
fluorescence microscopy and western blot.
Plasmids and shRNA Construction
To generate a lentiviral construct encoding short-hairpin RNA
(shRNA) specific to mouse RhoA, forward hairpin oligos 59-[Phos]
TGTCAAGCATTTCTGTCCAATTCAAGAGATTGGACAG-
AAATGCTTGACTTTTTTC -39 and reverse oligos 59-[Phos]
TCGAGAAAAAAGTCAAGCATTTCTGTCCAATCTCTTG-
AATTGGACAGAAATGCTTGACA -39 were annealed and
ligated into the HpaI and XhoI sites of the pLentiLox5.0 (pLL5.0)
vector (Addgene, Cambridge, MA). The dual cassette vector
(pLL5.0-shRNA) co-expresses enhanced green fluorescent protein
(EGFP) as a reporter gene and shRNA targeting mouse RhoA
under the control of CMV and the U6 promoter, respectively. For
expression of exogenous RhoA, plasmids encoding human RhoA
(GenBank Accession number: NM_001664), were directly con-
structed into the SacII and BamHI sites of the pLL5.0 vector with
an EGFP reporter under the control of CMV. All plasmid
constructions were verified by sequencing.
RhoA Activity Assays
RhoA activity assays were performed as described previously
[23]. Primary pericytes or cells expressing GFP vector or GFP-
tagged WT, CA or DN RhoA were cultured in serum free medium
containing TNF-a (15 ng/ml). Next day, cells were stimulated at
37uC for 1 hour by serum-free DMEM containing DMSO,
Forskolin (100 mM, Ascent Scientific, Princeton, NJ) or lysopho-
sphatidic acid (LPA, Enzo Life Sciences, Plymouth Meeting, PA)
(1 mg/ml)) or mouse PMNs, which were pretreated with DMSO or
phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich, Saint
Louis, MO) (100 ng/ml) and washed for four times with PBS.
Cells were lysed and incubated with glutathione S-transferase
(GST)-Rho binding domain (RBD) beads. Samples were washed
and then resolved by SDS-page gels. The endogenous RhoA in the
bound fraction (active) and in the whole cell lysates (total) was
immune-blotted with an anti-RhoA Ab (26C4, Santa Cruz
Biotechnology, CA). The exogenous active or total RhoA was
detected with an anti-GFP monoclonal Ab (Roche Applied
Science, Indianapolis, IN). The results were quantified using
Image J software. The relative amount of active RhoA was
determined by taking the ratio of RhoA sedimented by GST-RBD
beads to the amount of total RhoA.
Impedance-based Assay of Pericyte Responses to Either
Reagents or PMNs
Mouse primary pericytes were grown in serum free medium
containing TNF-a (15 ng/ml). Next day, 4.06104 cells were
seeded onto gold electrodes in each well (surface area of each well
is equal to 19.2 mm2/well) of a RTCA analyzer (Roche Applied
Science, Indianapolis, IN) and electrical impedance was moni-
tored over time. Changes in impedance may be used to measure a
number of characteristics of cells in a real-time manner including
cell spreading, degree of cell confluence, cell invasion, and
permeability of a cell layer, depending on the experimental design
(https://www.roche-applied-science.com/sis/xcelligence/index.
jsp?&id = xcect_020000). Here we use the RTCA analyzer to
monitor the spreading and morphology of pericytes within a
confluent culture and their response to a number of factors. To
verify our experimental results collected by the RTCA analyzer, in
some selected experiments, changes of cell morphology at
indicated time-points were analyzed in parallel, by imaging
techniques as detailed below. In an equivalent experiment using
96-well plates, we found that 4.06104 pericytes were able to make
a confluent cell monolayer and cover a surface of 19.2 mm2 2
hours after spreading. Our preliminary experiments indicated that
the impedance for each well reached a plateau from 2 to 6 hours
after cell seeding. Within this time frame, reagents such as DMSO,
PBS, Forskolin (100 mM), C3 Transferase (C3) (2 mg/ml, Cyto-
skeleton Inc, Denver, CO), Y27632 (10 mM, Calbiochem, Bill-
erica, MA), Blebbistatin (10 mM, Sigma-Aldrich, Saint Louis,
MO), Tolazoline (100 mg/ml), NE (10 mM), or LPA (1 mg/ml), or
5.06104 mouse PMNs, were added to the pericyte layers and the
impedance was recorded in real-time. In the case of adding PMNs,
these cells were pretreated with DMSO, saline, PMA (100 ng/ml),
or MnCl2 (2 mM) and extensively washed using 10 ml PBS at least
four times before adding to the pericyte monolayers.
Image-based Analysis of Pericyte Responses to Reagents
or PMNs
Coverslips (12 mm in diameter) placed in the wells of a 24 well
plate were pre-coated with human Fibronectin (FN, 10 mg/ml).
Mouse pericytes (primary cells or cells expressing GFP vector or
GFP-tagged WT, CA or DN RhoA) were grown in serum free
medium containing TNF-a (15 ng/ml). On the next day cells were
seeded onto each well at 37uC for 4 h, allowing cells to fully
spread. During this time period, PMNs were freshly isolated from
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mouse bone marrow and treated with DMSO, saline, PMA
(100 ng/ml), MnCl2 (2 mM) or recombinant murine CXCL1
(KC) (161027 M) at 37uC for 15 min. After being extensively
washed, 5.06105 pretreated PMNs were added onto the pericyte
layer at 37uC for 1 hour and cells were fixed in 4% PF.
Alternatively, chemicals such as DMSO, PBS, Forskolin (100 mM),
C3 (2 mg/ml), Y27632 (10 mM), Blebbistatin (10 mM), Tolazoline
(100 mg/ml), NE (10 mM), or LPA (1 mg/ml) were added at 37uC
for 1 hour to the cultures. In some selected experiments, pericytes
were co-incubated for 1 hour with mouse peritoneal PMNs or
PMNs which had passed across an endothelial cell layer and
migrated to IL-8 in the bottom well of a Boyden chamber
transwell system. Fixed cells were stained with Alexa-labeled
phalloidin (Invitrogen, Carlsbad, CA), Hoechst 33342 (Invitrogen,
Carlsbad, CA) and primary Abs against either paxillin (rabbit anti-
paxillin Abs, Abcam, Cambridge, MA) or phosphorylated myosin
light chain 2 (ser19) (anti-phospho-MLC Abs, Cell Signaling
Technology, Danvers, MA) plus appropriate fluorescent second
Abs and imaged using a Zeiss 510 Meta multi-photon confocal
microscopy with lasers excited at 488, 545, 633 and 740 nm
respectively, using a x63 oil objective (numerical aperture = 1.4).
To view the behavior of pericytes, DMSO- or PMA-pretreated
PMNs were added onto a TNF-a-induced pericyte layer, which
had been grown on a FN-coated glass surface of culture dishes
(MatTeK, Ashland, MA), and the interaction of pericytes and
PMNs was recorded with a 20 x A-Plan ph1 objective and an
ORCA ER CCD digital camera within a Zeiss Axiovert 200 M
inverted microscope equipped with a heating stage and a CO2
supply and driven by a MetaMorph 7.1.7 software (MDS
Analytical Technologies, Exton, PA).
Measurement of the Area of Gaps between Adjacent
Pericytes Grown in vitro
3.06105 mouse pericytes (primary cells or cells expressing GFP
vector or GFP-tagged WT, CA or DN RhoA) in serum free
medium containing TNF-a were seeded on FN-coated coverslips
(12 mm in diameter) placed in the wells of a 24 well plate
overnight. At this density, pericytes became confluent next day
and were labeled with Calcein green. 5.06105 DMSO- or PMA-
pretreated PMNs were labeled by Calcein blue and added on the
top of each pericyte monolayer for 1 hour. Alternatively,
compounds such as DMSO, Forskolin (100 mM), Tolazoline
(100 mg/ml), NE (10 mM), or LPA (1 mg/ml) were added. Cells
were fixed in 4% PF and 15 random fields per sample were
imaged using a 20 x A-Plan ph1 objective in a Zeiss Axiovert
200 M microscopy using the setting for phase contrast or
fluorescent images. The area of pericyte gaps (the area of negative
staining in terms of fluorescence intensity) was measured using
Image J software.
Transmigration of PMNs Through a Pericyte Single Layer
Within Boyden transwells, 4.06104 pericytes (primary cells or
cells expressing GFP vector or GFP-tagged WT or CA RhoA),
which were grown in serum free medium containing TNF-a
overnight, were seeded on the top surface of each FN-pre-coated
insert (with 3 mm pores). Three hours later, cells in the inserts were
stimulated with DMSO, Forskolin (100 mM), NE (10 mM), or NE
(10 mM) plus Tolazoline (100 mg/ml) at 37uC for 1 hour and
2.06105 of Calcein-green labeled resting PMNs were added into
each unit. Alternatively, pericytes were stimulated with 1.06105
DMSO- or PMA-pretreated PMNs for 1 hour followed by gentle
washes with PBS and then 2.06105 of Calcein-green labeled
resting PMNs were loaded into each insert. The inserts were put
back into the transwells which were filled with serum-free RP1640
medium containing 3 1028 M of IL-8 and incubated at 37uC for
4 h. Fluorescent PMNs which moved into the bottom wells were
counted.
Statistics
All results are expressed as means 6 s.e.m. Statistical
significance was assessed by one-way analysis of variance
(ANOVA) plus Neuman-Keuls multiple comparisons. Where two
variables were analyzed a Student’s t test was used. P,0.05 was
considered to be significant.
Results
Inflamed Venules Exhibit Expanded Pericyte Gaps and
Display Larger but Thinner LERs
Previous studies have suggested that the low expression regions
(LERs) of matrix proteins in the vascular basement membrane
(BM) act as channels for leukocyte transmigration and tend to
align with the gaps between pericytes. These LERs are plastic with
respect to their size and thickness during acute inflammation
[9,10]. However, little is known about how this phenomenon
occurs and whether pericytes contribute to the remodeling of the
vascular BM at these sites. To address this question, we injected
mouse cremaster muscles or skin with IL-1b or TNF-a to elicit
local acute inflammation. Two hours after injection, inflamed
tissues were fluorescently immunostained and imaged by confocal
microscopy. The area of gaps between adjacent pericytes,
indicated by negative staining of a-SMA (or PDGFR-b, data not
shown), and the area of LERs in the collagen type IV network
were measured. Our data showed that pericyte gaps were enlarged
after IL-1b injection (16.9860.43 mm2), compared to those in
untreated venules (9.7060.30 mm2) (Figure 1A, 1C). PMNs used
these gaps for transmigration (Figure 1A, 1B), which primarily
occur at post-capillary venules rather than capillaries (Figure S1).
In contrast, smooth muscle cells (SMCs), which share a common
origin with pericytes in venules [11], revealed compact coil-like
cell sheaths regularly surrounding the arterial vessels walls and few
gaps between SMCs could be found (Figure S2). Moreover we
were almost unable to detect PMN extravasation occurring in
arterioles during acute inflammation (Figure 1A and Figure S1).
This observation suggests that the occurrence of PMN extrava-
sation at venules relies, at least in part, on the existence of gaps
between adjacent pericytes in venular walls. Consistent with
previous studies, IL-1b-stimulated LERs, as judged by collagen
type IV immunofluorescence, expanded in area (Figure 1A, 1D)
and became thinner (Figure 1F). Importantly, our data revealed a
positive linear relationship between the area of pericyte gaps and
collagen IV LERs but a negative correlation with LER thickness
(Figure 1E, 1G). This is consistent with the expansion of pericyte
gaps contributing to the remodeling of the vascular BM as LERs
enlarge during acute inflammation.
PMN Transmigration Expands Pericyte Gaps and LERs
Since migrating leukocytes prefer to use pericyte gaps and LERs
in the vascular BM [9] and the expansion of pericyte gaps
contributes to the enlargement of LERs during acute inflamma-
tion, we asked whether PMN transmigration might regulate the
opening of pericyte gaps and hence the ensuing enlargement of
LERs. To examine this, we fluorescently immunostained resting or
IL-1b-injected mouse cremaster muscles and analyzed them using
confocal microscopy. Normally few PMNs were observed in the
lumen of resting venules (left panel in Figure 2A). Analyzing the
association of PMNs and vessel walls, we noted two types of
venular segments in IL-1b-stimulated tissues. In some segments
Pericytes Govern Neutrophil Extravasation
PLOS ONE | www.plosone.org 4 September 2012 | Volume 7 | Issue 9 | e45499
Pericytes Govern Neutrophil Extravasation
PLOS ONE | www.plosone.org 5 September 2012 | Volume 7 | Issue 9 | e45499
transmigrating and fully extravasated PMNs were seen (middle
panel in Figure 2A), whereas in others neither transmigrating nor
extravasated PMNs were observed in the venular walls or in the
perivascular tissues within 100 mm of these vessel segments (right
panel in Figure 2A). In the former type of vessel segments, we
refer to the pericyte gaps being used by transmigrating leukocytes,
as leukocyte-associated pericyte gaps (circled in the middle panel
in Figure 2A). In the latter, we refer to them as non-leukocyte-
associated pericyte gaps (boxed in the right panel in Figure 2A).
Accordingly, we refer to LERs as leukocyte-associated or non-
leukocyte-associated collagen IV LERs (Figure 1A). We found
that the average area of pericyte gaps in untreated venules was less
than that of non-leukocyte-associated gaps in IL-1b-stimulated
vessels (Figure 2B), implying a general expansion of pericyte gaps
occurs during inflammation induced by this cytokine. However,
leukocyte-associated pericyte gaps were even larger than those
non-leukocyte-associated (Figure 2B), suggesting that the inter-
action of pericytes with PMNs had expanded pericyte gaps. To
examine this possibility, we depleted most (.89%) of circulating
leukocytes using anti-Gr-1 antibodies [15]. This decreased the
number of both transmigrating and extravasated PMNs in
inflamed tissues (Figure 2C–2E). Since not all circulating PMNs
can be removed by Gr-1 antibodies, in situations where
transmigration occurred in anti-Gr-1 antibody-pretreated mice
(right panel in Figure 2C), the leukocyte-associated pericyte gaps
still had an average area similar to that found in animals
pretreated with control antibodies (Figure 2F). However, when
the total area of pericyte gaps and collagen IV LERs was
normalized to a 200 mm vessel segment, leukocyte-associated
pericyte gaps and collagen IV LERs in Gr-1 antibody-treated mice
were much smaller than in control mice (Figure 2G, 2H). These
experiments indicate that the presence of transmigrating PMNs
further expands pericyte gaps as well as the LERs.
Direct PMN-pericyte Contact Mediates Enlargement of
Pericyte Gaps and LERs
We next asked how migrating PMNs regulated the opening of
pericyte gaps. The pericyte response to leukocytes could be
mediated either by diffusible mediators or direct cell-cell contacts
[11,24]. Here we examined the role of direct contact between
PMNs and pericytes. We took advantage of the observation that
PMNs from PECAM-12/2 mice display retarded transit across
the IL-1b-stimulated venular BM within the first 4 hour time
frame after IL-1b injection due to their failure to express a6
integrin on their cell surface [17,20]. Hence in our study, we
injected IL-1b into the cremaster muscles of wild type (WT) or
PECAM-12/2 mice to induce inflammation and used them as
tools to test whether abolition of PMN-pericyte contact influenced
the opening of pericyte gaps. In IL-1b-injected PECAM-12/2
mice, the number of PMNs completing extravasation was
significantly lower than in WT mice (Figure 3A, 3B), despite
no difference in the number of PMNs involved in adhesion
(observed by intravital microscopy) or attempting transmigration
(Figure 3C). Migrating PECAM-12/2 PMNs might pass across
the endothelium but frequently stopped at the vascular BM, being
separated from the pericyte sheath by this barrier (bottom right in
Figure 3A), whereas WT PMNs broke through the vascular BM
and reached the pericyte sheath (bottom left in Figure 3A). This
measurement was previously confirmed by transmission electron
microscopy [17]. The average area of total pericyte gaps and non-
leukocyte-associated pericyte gaps in IL-1b-stimulated PECAM-
12/2 venules was greater than that in resting vessels, suggesting
that a general expansion of pericyte gaps also occurs in PECAM-
12/2 venular walls during acute inflammation. Unlike WT PMNs,
however, migrating PECAM-12/2 PMNs did not cause any
additional expansion of leukocyte-associated pericyte gaps
(Figure 3D). These observations indicate that transmigrating
PMNs separated from the pericyte sheath fail to enlarge pericyte
gaps beyond the level induced by IL-1b.
Using intravital microscopy, we noted that anti-ICAM-1
antibodies dramatically inhibited leukocyte adhesion to the
endothelium (data not shown). Immunostaining of whole-mounted
tissues revealed that these antibodies reduced both transmigrating
and extravasated PMNs in IL-1b-stimulated WT cremaster
muscles (Figure 3B, 3C). Anti-a6 integrin antibodies did not
influence the number of transmigrating PMNs in WT mice
(Figure 3C) but trapped these leukocytes in the vascular BM (data
not shown), therefore decreasing the number of emigrated PMNs
(Figure 3B). Importantly, we found that both these antibodies
markedly prevented expansion of both the leukocyte-associated
pericyte gaps and the LERs (Figure 3E, 3F), similar to what was
observed in PECAM-12/2 animals (Figure 3E–3G). Taken
together, these findings suggest that blocking contact between
PMNs and pericytes prevents the signaling in pericytes required to
expand the gaps between them.
Engagement with Activated PMNs Induces Pericyte
Relaxation
To examine the signaling initiated in pericytes by PMNs, we
incubated mouse primary pericytes with PMNs which were pre-
treated with DMSO- or phorbol 12-myristate 13-acetate (PMA),
an elevator of integrin expression as well as an activator of
integrins on the PMN surface [25,26]. Analyzed by time-lapse
images, no significant change in pericyte shape was observed after
pericytes were stimulated by DMSO-treated PMNs (Figure 4A),
whereas exposure to PMA-activated PMNs induced pericytes to
extend prominent lamellipodia, elongate and increase their
motility (Figure 4B, Movie S1 and Movie S2). In addition,
pericytes disassembled stress fibers and focal adhesions and
decreased myosin light chain (MLC) phosphorylation upon
stimulation of PMA-activated PMNs, indicative of cell relaxation
[27] (Figure 4C–4G).
At concentrations above 1 ng/ml, PMA induces a similar
phenotype in pericytes to that caused by PMA-activated PMNs
(data not shown). We were concerned that the effects of activated
PMNs on pericytes might be due to PMA leaching out of the
PMNs. To exclude this possibility, we developed two experimental
strategies. In one of these, we cultured pericytes on two sides of a
Figure 1. Expansion of pericyte gaps and collagen IV LERs in IL-1b-stimulated venular walls. (A) 3D images of vessel walls in mouse
cremaster muscles in the presence and absence of IL-1b revealed pericyte gaps and collagen IV LERs (circled areas) in venules. a-SMA (a marker of
venule pericytes and arteriole smooth muscles), collagen IV (a vascular BM marker) and MRP14 (a PMN marker). (B) Cross-sectional images revealed
PMNs migrating through pericyte gaps and collagen IV LERs (arrows) in an IL-1b-stimulated venule. (C) Distribution frequency of area of pericyte gaps
showed pericyte gap expansion induced by IL-1b (n = 2400). (D) Collagen IV LERs expanded in IL-1b-stimulated venular walls, compared to those in
untreated vessels (In each group, n = 1500). (E) The area of pericyte gaps (n = 1500) was plotted against the area of collagen IV LERs (n = 1500). (F)
Mean fluorescence intensity (MFI) of collagen IV in LERs decreased after IL-1b injection, indicating thinning of the vascular BM in these areas. (G) MFI
of collagen IV in LERs was plotted against the size of pericyte gaps. Bar = 10 mm. t test, ***P,0.001.
doi:10.1371/journal.pone.0045499.g001
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FN-coated coverslip and stimulated them with serum-free medium
containing TNF-a. After washes, PMA-activated PMNs were
added onto the top side of pericyte layers. Cells were fixed and
stained for F-actin. We found that pericytes on the top surface
(right image in Figure S3A) exhibited large lamellipodia and lost
actin stress fibers, compared to the cells growing on the bottom
surface (left image in Figure S3A) where contact with PMNs was
not possible. In another strategy, we collected the medium from
the tissue culture wells in which mouse primary pericytes had
interacted with PMA- or DMSO-treated PMNs and used these
conditioned medium to stimulate another batch of pericyte layers
growing on FN-coated coverslips. Consistent with the aforemen-
tioned results, exposure to PMA-treated (top left image in Figure
S3B) rather than DMSO-treated PMNs (top right image in
Figure S3B) led to loss of actin stress fibers and focal adhesions in
pericytes. However, conditioned medium collected from the wells,
in which either PMA-treated or DMSO-treated PMNs had
interacted with pericytes, had no influence on the morphology
and cytoskeleton in the second batch of pericytes (bottom images
in Figure S3B). These observations suggest that the pericyte
response was not induced by residual PMA, but rather resulted
from direct contact with activated PMNs that induced relaxation
of the pericyte actomyosin system.
We also examined pericyte morphology and cytoskeletal
organization in response to PMNs activated by more physiological
agents. PMNs treated with murine CXCL1 (KC), an inflamma-
Figure 2. Depletion of circulating PMNs decreases the expansion of pericyte gaps and collagen IV LERs during inflammation. (A) 3D
images showing the association of pericyte gaps and PMNs in mouse cremaster muscles that were untreated (left) or treated with IL-1b (middle and
right). Arrows indicated pericyte gaps and a circle showed PMNs migrating through pericyte gaps. In IL-1b-stimulated tissues, two types of venular
segments were noted. In some vessel segments (middle), both transmigrating and extravasated PMNs were seen. In others, no PMNs were found in
the vessel walls or within 100 mm of the perivascular tissues (right). In the first situation (middle), pericyte gaps being used by transmigrating PMNs
(circled area) are referred to as ‘‘leukocyte-associated pericyte gaps’’. In the second situation (right, boxed area), pericyte gaps are referred to as ‘‘non-
leukocyte-associated pericyte gaps’’. Note: we did not classify the pericyte gaps not circled in the middle panel since we were not sure whether these
gaps were used by leukocytes or not. However, these were included in the measurements when analyzing the total pericyte gaps. Similarly, collagen
IV LERs were described as ‘‘leukocyte-associated LERs’’ or ‘‘non-leukocyte-associated LERs’’. (B) Average area of pericyte gaps in untreated or IL-1b-
stimulated mouse cremaster muscle venules. (C) 2D images along the longitudinal axis of venules treated with IL-1b together with control or anti-Gr-
1 antibodies. Transmigrating PMNs are circled. (D) Number of transmigrating PMNs within venular walls treated with saline or IL-1b together with
control or anti-Gr-1 antibodies. (E) Number of extravasated PMNs within mouse cremaster muscles treated with saline or IL-1b together with control
or anti-Gr-1 antibodies. (F) Average area of pericyte gaps in untreated venules or vessels treated with IL-1b together with control or anti-Gr-1
antibodies. (G) The total area of leukocyte-associated pericyte gaps was normalized relative to a 200 mm length of vessel. (H) The total area of
leukocyte-associated collagen IV LERs was normalized relative to a 200 mm length of vessel. Bar = 10 mm. 5–6 mice were used in each treatment. In (B)
and (F), ANOVA plus Neuman-Keuls multiple comparisons were performed and in others, t tests were applied. *P,0.05, **P,0.01, and ***P,0.001,
compared to untreated groups. ###P,0.001, compared between gaps as indicated.
doi:10.1371/journal.pone.0045499.g002
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Figure 3. Direct cell-cell contact between transmigrating PMNs and pericytes mediates expansion of pericyte gaps and collagen IV
LERs. (A) 2D images of IL-1b-stimulated venules along the longitudinal axis. The areas outlined in the top panels are shown magnified in the bottom
panels, and reveal that transmigrating PECAM-12/2 PMNs become trapped at the vascular BM. (B) Number of extravasated PMNs in WT or PECAM-12/2
mouse cremaster muscles treated with saline or IL-1b, or in WT tissues injected with IL-1b together with control, anti-ICAM-1 or anti-a6 integrin
antibodies. (C) Number of transmigrating PMNs within WT or PECAM-12/2 venular walls treated with saline or IL-1b, or within WT vessels treated
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tory chemokine that has neutrophil chemoattractant activity [28],
induced a loss of stress fibers and focal adhesions, and decreased
MLC phosphorylation (Figure 4H–4L). Pericytes also exhibited a
relaxation phenotype (decreased stress fibers and focal adhesions)
after engagement with PMNs that had been stimulated with IL-8
and collected after passage across an endothelial cell layer in vitro
(Figure 4M, middle panel). We also induced an inflammatory
response in mouse peritoneal cavities by injection of thioglycollate.
PMNs were then isolated from the peritoneum and incubated with
pericytes. Again, we observed that these physiologically activated
PMNs induced a loss of pericyte stress fibers and focal adhesions
(Figure 4M, lower panel). Additionally, a similar phenotype
was seen when pericytes were exposed to PMNs that had been
activated by MnCl2, which increases integrin affinity [29,30]
(Figure S4).
Pericyte Relaxation Results from Inhibition of the RhoA/
Rho Kinase (ROCK) Signaling Pathway and Suppression of
Actomyosin-based Contractility
Because PMN interaction with pericytes induced stress fiber
disassembly, we examined the role of RhoA and its effector,
ROCK [31] in regulating pericyte contractility. Pericytes in
culture usually display prominent stress fibers and focal adhesions,
indicative of a high level of contractility. We examined whether
RhoA in cultured pericytes can be activated or inactivated after
exposure to different stimuli. To this end, a series of compounds
was added to primary pericyte cultures individually. Lysopho-
sphatidic acid (LPA) [32] increased RhoA activation in mouse
primary pericytes, while Forskolin, an elevator of cAMP [33],
inhibited its activation (Figure 5A). This suggested that RhoA
activation in pericytes could be either increased or suppressed in
our culture conditions, depending on the type of stimulus.
Morphological analysis demonstrated that RhoA activators,
including LPA and thrombin [34], did not have much effect on
pericyte shape. However, RhoA inhibitors such as Forskolin and
C3 Transferase (C3) [35] decreased MLC phosphorylation in
pericytes (Figure 5B, 5D) and induced loss of stress fibers and
focal adhesions (Figure 5C–5F) resulting in a migratory
phenotype. These responses are similar to those triggered by
interaction with activated PMNs.
In order to examine the effect of activated PMNs on RhoA
activity within pericytes, we used viral vectors to express GFP-
tagged WT RhoA in pericytes (Figure S5). In addition, we also
expressed GFP-tagged constitutively active (CA) Q63L or domi-
nant negative (DN) T19N RhoA or GFP alone in pericytes
(Figure S5). This allowed us to distinguish RhoA in pericytes
from RhoA in PMNs when investigating the two cell types
together. Activated PMNs decreased the activity of exogenously
expressed WT RhoA in pericytes when compared with non-
activated PMNs (Figure 6A). However, no depression was seen in
cells expressing the constitutively active RhoA (Figure S6). As
expected, LPA activated WT RhoA, whereas Forskolin inhibited
it. Neither treatment influenced the activity of CA or DN RhoA
(Figure S6).
Compared to cells expressing GFP alone, pericytes expressing
CA RhoA maintained prominent focal adhesions and stress fibers
after exposure to PMA-activated PMNs (Figure 6B). In addition,
knocking down endogenous RhoA by ShRNA led to loss of stress
fibers and focal adhesions in pericytes (Figure S5A, S5B and
Figure S7). We also examined pericyte response to Y27632 and
Blebbistatin, inhibitors for ROCK [36] and myosin ATPase [37]
respectively that are downstream of RhoA. We found that both of
these compounds decreased the phosphorylation of MLC and
induced disassembly of stress fibers and focal adhesions in
pericytes (Figure 7A–7E). Together these results support a model
in which activated PMNs induce the loss of stress fibers and focal
adhesions in pericytes by inhibiting the RhoA-ROCK pathway
leading to reduced pericyte actomyosin-based contractility [31,38].
Pericyte Relaxation Affects the Morphology of Pericyte
Monolayers
Our results suggest that the pericyte sheath serves as a barrier to
leukocyte extravasation. We wished to examine the barrier
properties of pericytes further and particularly the formation of
gaps between pericytes in tissue culture. However, unlike
endothelial cells, pericytes do not form monolayers in which
adjacent cells are held together by adherent junctions and tight
junctions. Consequently, conventional electrical resistance mea-
surements are not a practical approach for monitoring changes in
permeability as PMNs migrate across the pericyte monolayer.
However, electrical impedance measurements provide a measure
of cell area and adhesion to the underlying substratum [39,40] and
we have taken advantage of this approach. Compounds decreasing
actomyosin contractility, including Forskolin, C3, Y27632 and
Blebbistatin, decreased the impedance of pericyte layers and led to
a relaxation phenotype of pericytes (Figure 8A, 8B, Figure 5
and Figure7). However, agents that increased RhoA activity
slightly increased or had no effect on impedance (data not shown).
Incubating the pericytes with PMA-activated or MnCl2-activated
PMNs reduced impedance of the pericyte layer (Figure 8C and
Figure S4). Examining pericyte monolayers revealed that the
spaces between pericytes were enlarged by activated PMNs and by
the presence of relaxants, such as Forskolin or C3 (Figure 8D,
8E). Agents that stimulate contraction, such as LPA, did not
induce or expand the gaps between pericytes (Figure 8D).
Pericyte Relaxation Facilitates PMN Transmigration both
in vitro and in vivo
Our data are consistent with a model in which PMN interaction
with pericytes induces pericyte relaxation and a consequent
expansion of the gaps between pericytes, thereby facilitating
passage of PMNs across the pericyte sheath. We wished to
determine whether agents that affect pericyte contractility in vivo
may affect PMN passage across the pericyte layer. Two drugs that
have been used clinically to induce vasoconstriction or vasodilation
are Norepinephrine (NE) and Tolazoline, respectively. NE is an
agonist [41] of a-adrenergic receptors in pericytes and smooth
muscle cells, whereas Tolazoline is an antagonist [42]. We first
with IL-1b together with control, anti-ICAM-1 or anti-a6 integrin antibodies. (D) Average area of pericyte gaps in untreated or IL-1b-injected WT or
PECAM-12/2 venules in mouse cremaster muscles. (E) The area of leukocyte-associated pericyte gaps was compared for WT and PECAM-12/2cremaster
muscles, as well as with those treated with the indicated antibodies. (F) The area of leukocyte-associated collagen IV LERs was compared for WT and
PECAM-12/2cremaster muscles, as well as with those treated with the indicated antibodies. (G) The normalized MFI of leukocyte-associated collagen IV
LERs was compared for WT and PECAM-12/2 cremaster vessels, as well as with those treated with the indicated antibodies. Bar = 10 mm. 7–8 mice for
each treatment. In panel (D), (E) and (F), ANOVA plus multiple comparisons (Comparisons with untreated (D) or control Ab (E, F) groups were displayed
by *. Additional comparisons between two different groups were indicated by #), and in others, t tests were performed. * or #P,0.05, **P,0.01, and
***P,0.001.
doi:10.1371/journal.pone.0045499.g003
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examined the response of pericytes to these agents in pericyte
cultures. Our data demonstrated that pericytes maintained their
actin stress fibers and focal adhesions in response to NE but lost
these structures in the presence of Tolazoline (Figure 9A). NE
activated RhoA and slightly increased the impedance of pericyte
monolayers, whereas Tolazoline decreased RhoA activity and
decreased the impedance of cultures (Figure 9B, 9C). Image
analysis of pericyte monolayers revealed that gaps between
pericytes were enlarged by the presence of Tolazoline whereas
NE did not induce or expand the gaps between pericytes
(Figure 9D, 9E).
We next examined the ability of PMNs to pass across pericyte
monolayers grown on FN-coated filters of a Boyden transwell
system. Due to strong adhesion to the pericytes and the filters,
migration of PMA-activated PMNs toward IL-8 in the lower
chamber was less than control PMNs (See the first two bars in
Figure 10A). However, as discussed above, engagement of
activated PMNs expands pericyte gaps. Pre-exposure of pericyte
monolayers to activated PMNs induced an increased transmigra-
tion (six fold) of a second batch of Calcein-AM-labeled resting
PMNs. This response was diminished when the pericyte layers
expressed CA RhoA (Figure 10A). In addition, more PMNs
passed through pericyte layers pretreated with relaxants such as
Forskolin and Tolazoline than through layers treated with NE or
vehicles (e.g. DMSO or PBS) (Figure 10B). These findings
indicate that migration of PMNs across pericyte monolayers is
promoted by inhibiting pericyte contractility, which results in the
expansion of gaps between pericytes.
To examine whether modulating the contractility of pericytes
affects PMN transmigration in vivo, we topically applied NE or
Tolazoline to exteriorized cremaster muscles which had been pre-
stimulated with IL-1b. Treatment with Tolazoline significantly
enlarged pericyte gaps (Figure 11A). In addition, Tolazoline
induced an expansion of the LERs and caused these to become
thinner (i.e. there was decreased collagen fluorescence intensity)
(Figure 11B, 11C). Examining the distribution of PMNs, we
observed that Tolazoline released PMNs from the space between
ECs and pericytes, reducing the number of PMNs within the vessel
wall (Figure 11D, 11E) but increasing the number of extrava-
sated leukocytes (Figure 11D, 11F). In contrast, NE decreased
the area of pericyte gaps and LERs, compared to a saline control
(Figure 11A, 11B). NE tended to increase the number of PMNs
in the space between ECs and pericytes but decrease the number
of PMNs that successfully completed extravasation (Figure 11D–
11F). These in vivo data further support that relaxation of pericytes
expands the gaps between them, as well as the adjacent LERs, to
facilitate PMN passage across inflamed venular walls.
Discussion
The passage of leukocytes across the venule wall is a critical
event during inflammation that allows the recruitment of
leukocytes out of the blood circulation to sites of infection or
tissue damage. In venular walls the endothelium forms the first
barrier to transmigrating leukocytes while the pericyte sheath,
which is embedded in the vascular BM, provides a second barrier
surrounding the endothelium [4]. Most attention has been paid to
how leukocytes interact with and cross the endothelium, whereas
little work has been directed toward understanding the passage of
leukocytes across this second barrier [4,5,6]. However, migrating
leukocytes tend to accumulate in the space between the
endothelium and the vascular BM [7,8] indicating the potential
importance of this barrier. Previous studies demonstrated that
PMNs crossing the venular BM selectively targeted regions of low
extracellular matrix expression, which have become known as
LERs, and that these sites tended to align with gaps between
pericytes [9]. In addition, these previous studies discovered that
LERs were plastic with respect to their size and thickness and
underwent remodeling during leukocyte transmigration, creating
channels for leukocyte extravasation [9,10]. Although enzymatic
cleavage of matrix proteins in the vascular BM has been suggested
as a potential mechanism underlying LER remodeling at sites of
acute inflammation [9,43], monocytes seem not to rely on
proteolysis of the vascular BM during their extravasation [43],
implying that other factors may be involved in inflammation-
induced LER remodeling. In this earlier work, pericytes were
simply treated as reference points to indicate the location of LERs
in the vascular BM. The potential role of pericytes in regulating
LER remodeling and hence leukocyte extravasation was not
addressed. However, the location of pericytes and their morphol-
ogy (i.e. forming a sheath that is embedded in the vascular BM
surrounding the vessel walls with gaps between adjacent pericytes
aligning with LERs), coupled with their capacity to contract or
relax [11], imply that structural changes in the pericyte sheath
may influence PMN transmigration. Here we have investigated
leukocyte interactions with pericytes and discovered that engage-
ment with PMNs induces expansion of pericyte gaps and thinning
of their associated LERs. Working with pericytes in culture, we
show that activated PMNs bind to pericytes and initiate a signaling
cascade that inhibits the RhoA/ROCK pathway, thereby
inducing pericyte relaxation.
Our current data reveal pericytes to be active participants in the
remodeling of LERs during PMN transmigration. This is distinct
from the pericyte-mediated BM remodeling that occurs in some
patho-physiological conditions such as angiogenesis [44]. In the
latter case, BM remodeling is a long-term event that involves both
degradation and reassembly of matrix proteins [45] and even the
renewal of pericytes.
To get at the role of PMN interactions with pericytes in the
regulation of LERs and pericyte gaps, we used a number of
strategies to perturb PMN transit across venule walls during
inflammation. Using IL-1b to induce local inflammation in mouse
cremaster muscles, we were able to quantify the size of LERs,
pericyte gaps and their relationship to migrating PMNs. Treat-
Figure 4. Engagement of activated PMNs induces pericyte relaxation. (A) Changes in mouse pericyte morphology before and after adding
DMSO-treated PMNs or (B) before and after adding PMA-treated PMNs. (C) After incubation of DMSO- or PMA-treated PMNs with mouse primary
pericytes, cells were fixed and stained for F-actin (green), nuclei (blue), and paxillin (red) or phosphorylated MLC (red) (D). (E) Change in the level of
phosphorylated myosin light chain (phospho-MLC) in pericytes responding to DMSO- or PMA-treated PMNs. Change in the area (F) and the number
(G) of focal adhesions in pericytes responding to DMSO- or PMA-treated PMNs. (H) Change in the level of phospho-MLC in pericytes responding to
NaCl- or CXCL1-treated PMNs. Change in the area (I) and the number (J) of focal adhesions in pericytes responding to NaCl- or CXCL1-treated PMNs. T
test, *P,0.05, **P,0.01 and ***P,0.001. (K) Response of mouse pericytes to PMNs activated by CXCL1. Cells were stained for F-actin (green), paxillin
(red) and nuclei (blue). (L) Response of mouse pericyte to PMNs activated by CXCL1. Cells were stained for F-actin (green), phospho-MLC (red) and
nuclei (blue). (M) Response of mouse pericytes to PMNs that have passed across an endothelial layer in vitro in response to IL-8 or that have been
collected from the mouse peritoneal cavity following thioglycollate intra-peritoneal injection. Cells were stained for F-actin (green), paxillin (red) and
nuclei (blue). Bar = 10 mm.
doi:10.1371/journal.pone.0045499.g004
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Figure 5. Inhibition of endogenous RhoA leads to a relaxation phenotype in pericytes. (A) Mouse primary pericytes were treated with
LPA, Forskolin (For) or their vehicles. RhoA activity in cell lysates was detected using a pull-down assay. n = 5, t test and **P,0.01 as indicated. (B)
Mouse primary pericytes were untreated or treated with LPA or Forskolin. Cells were fixed and stained for F-actin, phospho-MLC and nuclei (shown in
blue). (C) Mouse primary pericytes were treated with different compounds such as Thrombin, C3, LPA and Forskolin. Cells were fixed and stained for
F-actin, paxillin and nuclei (shown in blue). Bar = 10 mm. (D) Change in the level of phosphorylated MLC in pericytes responding to different
compounds. Change in the area (E) and the number (F) of focal adhesions in pericytes responding to the different compounds. Three independent
experiments and $10 fields/experiment were analyzed in D, E and F. T test, *P,0.05, **P,0.01 and ***P,0.001, compared to vehicles (i.e. DMSO or
PBS).
doi:10.1371/journal.pone.0045499.g005
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Figure 6. Engagement of activated PMNs inhibits RhoA activity in pericytes. (A) Pericytes expressing GFP-tagged WT human RhoA were
exposed to DMSO-treated or PMA-treated PMNs. Activity of GFP-tagged RhoA was detected. n = 3, t test. ***P,0.001. (B) Pericytes expressing GFP-
vector or GFP-tagged CA human RhoA were exposed to DMSO-treated or PMA-treated PMNs for one hour. Cells were fixed and stained for F-actin
(green), paxillin (red), and nuclei (blue). GFP was shown in white. Expression of CA RhoA in pericytes blocked the response induced by PMA-treated
PMNs. Bar = 10 mm.
doi:10.1371/journal.pone.0045499.g006
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ment with IL-1b induced expansion of pericyte gaps and LERs.
We noted that PMN extravasation usually occurs preferentially in
some venule segments but not others that are nearby and appear
similar. The reason for these ‘‘hot spots’’ of PMN migration out of
inflamed venules is not clear and merits further investigation.
However, within the venular regions of preferred PMN transit, we
noted that the pericyte gaps and LERs associated with transmi-
grating leukocytes were bigger than those in other vessel segments
suggesting that the presence of leukocytes contributed to the
expansion of these regions. To explore this further we depleted
circulating leukocytes and this decreased both the size of the
pericyte gaps and the LERs within the BM, as judged by collagen
IV staining. This effect could be due to soluble factors secreted by
the PMNs or the result of direct PMN-pericyte contacts. To
determine whether cell-cell contact might be involved in this effect
of PMNs on pericytes, we took advantage of previous studies
indicating that transmigrating PECAM-12/2 PMNs frequently
become trapped in the IL-1b-stimulated vascular BM at a
relatively early stage of acute inflammation before they reach
the pericyte sheath. These cells fail to penetrate the vascular BM
due to their inability to express a6 integrin [17,20], which is
required for migrating PMNs to bind to the vascular BM. Using
IL-1b-injected PECAM-12/2 mice as tools, we found separation
of PMNs from the pericyte sheath by the vascular BM in these
mice. Notably, we observed a decreased expansion of pericyte gaps
and LERs compared with wild type mice. We also used anti-
Figure 7. Inhibition of ROCK or myosin ATPase, downstream of RhoA, induces a relaxation phenotype in pericytes. (A) Mouse primary
pericytes were treated with the inhibitors Y27632 or Blebbistatin. Cells were fixed and stained for F-actin, phospho-MLC and nuclei. (B) Mouse
primary pericytes were treated with the inhibitors Y27632 or Blebbistatin. Cells were fixed and stained for F-actin, paxillin and nuclei. Bar = 10 mm. (C)
Change in the level of phosphorylated MLC in pericytes responding to different compounds. Change in the area (D) and the number (E) of focal
adhesions in pericytes responding to the different compounds. Three independent experiments and $10 fields/experiment were analyzed in C, D
and E. T test, *P,0.05, **P,0.01 and ***P,0.001.
doi:10.1371/journal.pone.0045499.g007
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ICAM-1 and anti-a6 integrin antibodies to block transmigration at
the stages before PMNs meet the pericyte sheath. Perfusing
animals with these antibodies led to smaller size of pericyte gaps
and LERs. Together these observations suggest that direct
contacts between migrating PMNs and pericytes contribute to
the opening of pericyte gaps and the expansion of LERs.
To explore the signaling pathway triggered by PMN/pericyte
interactions, we used PMNs activated in several ways. For many
experiments, we have used PMA to induce activation, but to
obtain more physiologically relevant activated PMNs, we have
activated some with CXCL1 or we have used PMNs retrieved
after they have been stimulated by IL-8 to pass through an
endothelial monolayer. We also isolated PMNs from the peritoneal
cavity after induction of inflammation by intra-peritoneal injection
of thioglycollate. In a few experiments, PMN integrins were
selectively activated by exposure to MnCl2. We found that
activated PMNs bound to pericytes, induced a change in pericyte
shape, increased the size of gaps between pericytes in culture and
promoted PMN passage across this cell layer. We were surprised
to observe that in response to the activated PMNs, the pericytes
Figure 8. Relaxation of pericytes expands pericyte gaps in a pericyte monolayer. (A)–(C) On the left, the relative impedance is shown for
pericytes responding to different treatments. Representative real-time read-outs are shown on the right. The relative impedance at 1 hour after
adding a chemical (indicated by the red vertical line) was normalized to the impedance when reagents or cells were added (indicated by the black
vertical line). In (A), the effects of Forskolin or C3 were analyzed, and in (B), the effects of Y27632 or Blebbistatin were compared. (C) the effect of
DMSO- or PMA-treated PMNs on the impedance of primary pericyte monolayers. (D) Change in area of pericyte gaps in culture. Calcein green-labeled
pericytes were grown to confluence on FN-coated coverslips in the wells of a 24 well plate. Compounds such as LPA or Forskolin, or Calcein blue-
labeled mouse PMNs, pretreated with DMSO or PMA, were added to pericyte monolayers for 1 hour. Cells were fixed and imaged. The area of pericyte
gaps was measured. (E) Representative images showing the change in size of gaps between pericytes upon stimulation of DMSO- or PMA-pretreated
PMNs. Prominent pericyte gaps are indicated by white X’s. Note: The same amount of DMSO- or PMA-treated PMNs were added onto pericyte
monolayers. However, due to the change in pericyte morphology and PMA-treated PMN transmigration, the density of both PMNs and pericytes
looks lower in the PMA-treated group. Bar = 50 mm. n = 4–5. T test as indicated. *P,0.05, ** or ##P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0045499.g008
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Figure 9. Effect of vasoactive drugs, NE and Tolazoline, on pericyte morphology and permeability of pericyte monolayers. (A) Mouse
primary pericytes were treated with buffer, NE or Tolazoline. Cells were fixed and stained for F-actin, paxillin and nuclei. Bar = 10 mm. (B) NE increased
RhoA activity in pericytes while Tolazoline inhibited it. NE or Tolazoline were added to pericytes and RhoA activity was measured in a pull-down
assay. n = 5. T test. *P,0.05 and **P,0.01, compared to vehicle. (C) Effects of NE, Tolazoline or NE + Tolazoline on the impedance of a pericyte
monolayer were compared. On the left, the relative impedance was shown for pericytes responding to different treatments. Representative real-time
read-outs were shown on the right. The relative impedance at 1 hour after adding a chemical (indicated by the red vertical line) was normalized to
the impedance when reagents or cells were added (indicated by the black vertical line). n = 4–5. T test as indicated. P,0.05 and **P,0.01. (D) Change
in area of pericyte gaps in culture. Pericytes were grown to confluence on FN-coated coverslips in the wells of a 24 well plate. NE, tolazoline, or NE
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disassembled their stress fibers and focal adhesions and decreased
MLC phosphorylation, indicative of decreased pericyte contrac-
tility. Only when pericytes directly engaged with activated PMNs,
did these reactions occur. In contrast, pericytes maintained their
morphology and sub-cellular structures such as stress fibers and
focal adhesions when pericytes were stimulated by the conditioned
medium collected from the tissue culture wells in which activated
PMNs had interacted with another batch of pericytes. These
observations suggested that direct engagement with PMNs was
essential to induce this response. The loss of stress fibers and focal
adhesions in pericytes responding to activated PMNs suggested
that this may involve inhibition of the RhoA/ROCK pathway in
pericytes [31,46]. Consistent with this possibility, expression of
constitutively active RhoA in pericytes blocked this response.
Inhibiting RhoA, ROCK or myosin ATPase in control cultures of
pericytes induced a phenotype similar to that induced by activated
PMNs. Because of the difficulty of measuring endogenous pericyte
RhoA activity in mixed cultures containing both PMNs and
pericytes, we expressed epitope-tagged versions of RhoA in
pericytes. Activated PMNs decreased the activity of RhoA in the
pericytes. This was not seen when the pericytes were incubated
with PMNs that had not been activated. These results suggested
that engagement of activated PMNs with mouse primary pericytes
enlarges pericyte gaps by inducing pericyte relaxation via
inhibition of the RhoA/ROCK pathway and suppression of
actomyosin-based contractility [46]. Future efforts will be directed
at identifying the adhesion molecules on pericytes and PMNs that
mediate this interaction and decrease pericyte RhoA activity.
The finding that pericyte relaxation expands the gaps between
these cells is unexpected and contrasts with the opening of EC
gaps during neutrophil transendothelial migration, which is
associated with RhoA activation and increased tension on EC
junctions [47,48]. How might relaxation of pericytes expand the
gaps between them? Neutrophil engagement with pericytes in
culture induces the pericytes to become more elongated and
narrow, in association with increased motility. Increased pericyte
motility has been observed in some acute conditions such as
ischemia and reperfusion in vivo [49], and may result in long term
remodeling of the matrix. While cell shape changes may
contribute to the expansion of pericyte gaps, pericyte relaxation
leading to vasodilation may also be a factor. Pericyte contractility
regulates the diameter of capillaries [50] and the contractile
properties of pericytes may similarly regulate venule diameter.
Indeed, venule dilation has been observed during the late stages of
inflammation and is accompanied by leukocyte margination [51].
Venule dilation should stretch the pericyte sheath, expanding the
gaps between pericytes because the adhesions between pericytes
appear to be much weaker than their adhesions to the BM.
Stretching the vascular BM between pericytes should also
contribute to thinning of the LERs. It is interesting that ECs
and pericytes contribute to the regulation of neutrophil extrava-
sation by seemingly opposite mechanisms.
We argued that if our model is correct and the size of the
pericyte gaps and the LERs is governed by the contractile state of
the pericytes, we ought to be able to manipulate the contractile
state of pericytes directly and thereby affect gap size and influence
PMN migration through inflamed venule walls. To enhance
pericyte contraction we applied NE and to relax pericytes we
applied Tolazoline locally to IL-1b-treated cremaster muscles.
Whereas NE slightly decreased the size of the pericyte gaps or
LERs and tended to increase the number of PMNs in the space
between ECs and pericytes, Tolazoline induced a significant
expansion of the gaps and LERs. Additionally, Tolazoline reduced
the number of PMNs within the venule wall and increased the
number of PMNs that successfully extravasated through the venule
wall into the adjacent tissue. Together our results indicate that the
transit of leukocytes across inflamed venule walls is regulated in
part by the contractile state of pericytes that controls the size of the
LERs in the venular BM and the dimensions of the gaps between
pericytes. Previous work has described LERs as ‘‘gates’’ for
plus Tolazoline were added to pericyte monolayers for 1 hour. Cells were fixed and imaged. The area of pericyte gaps was measured. n = 5. T test as
indicated. **P,0.01. (E) Representative images showing the change in size of pericyte gaps upon stimulation of vehicle buffer, NE or NE plus
Tolazoline. Pericyte gaps are indicated by red *’s. Bar = 50 mm.
doi:10.1371/journal.pone.0045499.g009
Figure 10. Relaxation of pericytes facilitates PMN transmigration in vitro. (A) Pericyte engagement with PMA-activated PMNs enhanced
PMN passage across a pericyte monolayer. n = 5. Note: Due to strong adhesion to the pericytes and the filters, migration of PMA-activated PMNs
toward IL-8 in the lower chamber was less than that of control PMNs (See the first two bars). (B) PMN transmigration through a pericyte monolayer in
the presence of agents that affect pericyte contractility. n = 4. *P,0.05 and **P,0.01 as indicated.
doi:10.1371/journal.pone.0045499.g010
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leukocyte transit through the venular wall [4,9,10] but has not
addressed the mechanisms controlling the opening of these gates.
Our work suggests that pericytes play a key role in regulating the
size of these gates through which leukocytes migrate, following a
potential pathway that is illustrated in Figure S8. As such,
pericytes present a potential target for the development of
therapeutic agents aimed at decreasing leukocyte recruitment in
inflammatory diseases.
Compared to the extensive literature examining how PMNs
interact with endothelial cells during PMN extravasation, our
understanding of the role of pericytes in this event is just starting.
In addition, some physical and functional associations exist
between endothelial cells and pericytes in venular walls and
during the development of the vasculature [11,52,53]. The role of
these interactions, which has generally been ignored, will need to
be investigated during PMN diapedesis.
Figure 11. Relaxation of pericytes facilitates PMN transmigration in vivo. (A) Change in area of pericyte gaps in IL-1b-stimulated venular
walls exposed to Tolazoline or NE. (B) Change in area of collagen IV LERs in IL-1b-stimulated venules treated with Tolazoline or NE. (C) Change in MFI
of collagen IV LERs in IL-1b-stimulated venular walls treated with Tolazoline or NE. (D) Representative images of IL-1b-stimulated cremaster muscle
venules illustrating the effect of Tolazoline and NE on PMN transmigration in vivo. The top panels show 2D images from the middle sections of these
venules, stained as indicated to reveal transmigrating and extravasated PMNs. Higher magnifications of the boxed areas (marked with Arabic
numerals) are displayed on the right. The bottom 3D images are reconstructions of the same venules stained as indicated to reveal extravasated
PMNs. (E) Number of PMNs in the process of transmigrating in IL-1b-stimulated cremasters treated with saline, Tolazoline or NE. (F) Number of
extravasated PMNs in the perivascular tissues 100 mm around a 200 mm vessel segment in IL-1b-injected mouse cremaster muscles. 7–8 mice and 15
vessel segments from each mouse were analyzed in each group of the experiments displayed. Bar = 10 mm in the zoom-in views, and = 50 mm in
other images. ANOVA plus multiple comparisons were performed. Comparisons with saline control were displayed by *P,0.05, **P,0.01, and
***P,0.001. Other comparisons were indicated as ##P,0.01 and ###P,0.001.
doi:10.1371/journal.pone.0045499.g011
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After this work was completed, a paper by Proebstl et al. was
published analyzing the migration of neutrophils across venular
walls during inflammation [54]. In that study, neutrophils were
imaged crossing the endothelium and then migrating beneath the
endothelial cells and along pericyte processes. The neutrophils
were observed to pass through gaps between the pericytes, as we
have described here. Like our work, they showed that inflamma-
tion induced expansion of the gaps. However, in this other study,
the expansion of the gaps between pericytes was attributed solely
to the effects of inflammatory cytokines, whereas we provide
evidence that, in addition to the action of inflammatory cytokines,
the interaction of leukocytes with pericytes contributes to the
enlargement of the pericyte gaps. In the present study we also
provide evidence that the expansion of the gaps is due to a
decrease in the RhoA/ROCK signaling pathway that results in
relaxation of the pericytes.
Supporting Information
Figure S1 Expression of a-SMA in microvasculature and
occurrence of PMN extravasation. (A) Representative
images show different types of vessel segments, among which
PMN extravasation occurred primarily at the post-capillary
venule. Mouse cremaster muscles were injected with IL-1b. Two
hours later, tissues were collected, immuno-stained for a-SMA,
MRP14 and PECAM-1, and imaged in 3D. The areas outlined in
the merged image panel are shown magnified in the corresponding
panels as indicated, so as to reveal the expression of a-SMA and
PECAM-1 in the arteriole, capillary and venule. Note: due to the
relatively higher expression of a-SMA in the arteriole, the arteriole
image intensity was saturated. Bar = 10 mm. (B) Quantitation of
PMNs extravasated from capillaries, post-capillary venules or
arterioles in mouse cremaster muscles or skin which were
stimulated by either IL-1a or TNF-a. Ten vessel segments/mouse
and four mice/group were analyzed. ANOVA plus Neuman-
Keuls multiple comparisons were performed as indicated. ***
P,0.001. (C) TNF-a-injected mouse cremaster muscles were
immuno-stained for smooth muscle actin, PECAM-1 and MRP14
and imaged in 3D. a-SMA staining in capillaries was faint and
even negative (indicated by yellow arrows in the merged image)
but strong in post-capillary venules (indicated by a white solid
arrow). PMN extravasation took place at the post-capillary venule.
Bar = 10 mm.
(TIF)
Figure S2 a-SMA staining in an arteriole, a post-
capillary venule, and a collecting venule of mouse
cremaster muscles. Resting tissues were immuno-stained for
a-SMA, imaged in 3D and displayed at high magnification. In the
arteriole, a-SMA positive cells (i.e. smooth muscle cells) regularly
surrounded the vessel like compact coils. However, a-SMA
positive cells intricately presented in the post-capillary venule
and extended a number of longitudinal and circumferential
processes (indicated by green arc arrows), exhibiting a typical
pericyte phenotype. Gaps between adjacent cells were marked by
yellow arrows. In the collecting venule, a-SMA positive cells (i.e.
muscle cells) regularly coiled around the vessel wall.
(TIF)
Figure S3 Direct contacts with PMA-activated PMNs
lead to pericyte relaxation. To further confirm that pericyte
responses to PMA-treated PMNs were mediated by direct cell-cell
contacts between PMNs and pericytes rather than by the residual
PMA in the culture medium, we developed two experimental
strategies as described below. (A) In serum-free medium
containing TNF-a (15 ng/ml), mouse primary pericytes were
grown on two sides of a FN-coated coverslip placed in the well of a
24 well plate overnight. After being extensively washed, PMA-
treated PMNs were added on the pericyte layer growing on the top
surface of coverslips for one hour. Cells were fixed and stained for
F-actin and nuclei. Pericytes on the top surface (left image)
exhibited large lamellipodia and lost actin stress fibers, compared
to the cells growing on the bottom surface (right image). (B) In
serum-free medium containing TNF-a (15 ng/ml), mouse primary
pericytes were grown on FN-coated coverslips placed in the well of
a 24 well plate overnight. After being extensively washed, PMA- or
DMSO-treated PMNs were added. One hour later, the condi-
tioned medium was collected from these wells and any
contaminating cells (probably including some pericytes and PMNs)
were removed by centrifugation. These conditioned media were
added to another batch of pericytes growing on FN-coated
coverslips. Cells were fixed and stained for F-actin, paxillin and
nuclei. Exposure to PMA-treated (top left image) rather than
DMSO-treated PMNs (top right image) led to loss of actin stress
fibers and focal adhesions in pericytes. However, conditioned
medium collected from the wells, in which either PMA-treated
(bottom left image) or DMSO-treated PMNs (bottom right image)
had interacted with pericytes, had no influence on the morphology
and cytoskeleton in the second batch of pericytes. Arrowheads
indicate PMNs. Bar = 10 mm. Data shown in (A) and (B) suggest
that direct contacts with PMA-activated PMNs mediate pericyte
relaxation.
(TIF)
Figure S4 Engagement of MnCl2-activated PMNs leads
to pericyte relaxation and increases permeability of
pericyte monolayers. (A) TNF-a-induced pericytes were
grown on FN-coated coverslips. NaCl- or MnCl2-treated PMNs
that had been extensively washed after stimulation were added for
1 hour. Cells were fixed and stained for nuclei, F-actin and
paxillin. MnCl2-treated PMNs induced partial loss of actin stress
fibers and focal adhesions in pericytes. (B) TNF-a-induced mouse
primary pericytes were seeded on the wells of a RTCA analyzer
for 3 to 5 hours to make a confluent cell monolayer. NaCl- or
MnCl2-treated PMNs were respectively added to each well for one
more hour. The impedance of a pericyte monolayer was recorded
in time-lapse. As demonstrated by the representative experimental
curves in the right graph, the relative impedance at 1 hour after
adding NaCl- or MnCl2-treated PMNs (indicated by red vertical
line) was normalized to that when PMNs were added (indicated by
black vertical line). Exposure to MnCl2-treated PMNs caused a
decrease of the impedance in pericyte monolayers (left bar graph).
T test, *P,0.05.
(TIF)
Figure S5 Sequence of shRNA specific to mouse RhoA
and expression of exogenous GFP-targeted RhoA. To
analyze the role of RhoA in pericytes interacting with PMNs, we
infected mouse primary pericytes with lentivirus bearing a GFP
reporter and short-hairpin RNA (shRNA) to knock down RhoA in
mouse pericytes. In some cases, we expressed exogenous GFP-
tagged wild type (WT), constitutively active (CA) Q63L or
dominant negative (DN) T19N RhoA in mouse primary pericytes.
This allowed us to distinguish RhoA in pericytes from RhoA in
PMNs when investigating pericyte interactions with PMNs. (A)
ShRNA-targeted sequence of mouse RhoA is displayed, as well as
the expression levels of endogenous RhoA in mouse MEF cells and
primary pericytes as revealed by western blots in control cells or
following knockdown by the shRNA. (B) Expression of exogenous
GFP-tagged human RhoA in mouse primary pericytes was
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revealed by western blots. (C) Representative images showed
expression of GFP or GFP-tagged RhoA in mouse primary
pericytes. Nuclei were displayed in blue. Approximately 90% GFP
positive cells were achieved. Bar = 50 mm.
(TIF)
Figure S6 Assay of GFP-tagged RhoA in pericytes after
exposure to different chemicals or engagement with
PMNs. Pericytes expressing GFP-tagged CA, DN or WT human
RhoA were starved in serum-free medium supplied with TNF-a
overnight and exposed to the indicated reagents or to DMSO-
treated or PMA-treated PMNs. Activity of GFP-tagged RhoA was
detected (n = 7 for pericytes treated with chemicals and n = 3 for
pericytes interacting with PMNs. t test. * P,0.05 and ** P,0.01
as indicated).
(TIF)
Figure S7 Knocking down RhoA expression leads to a
relaxation phenotype in pericytes. Mouse pericytes were
infected with lentivirus carrying GFP empty vector, or GFP-tagged
human WT RhoA or shRNA specific to mouse RhoA. Cells were
seeded on FN-coated coverslips and stained for F-actin (green),
paxillin (red) and nuclei (blue). Samples were imaged and GFP was
displayed in white. Compared to GFP-negative cells or those
expressing GFP empty vector or GFP-tagged WT RhoA, pericytes
bearing shRNA for RhoA extended protrusions and lost stress
fibers and focal adhesions. Bar = 10 mm.
(TIF)
Figure S8 A diagram illustrating the interactions of
PMNs migrating across a venule wall. The top diagram
demonstrates the structure of a venule wall, illustrating that the
endothelium contacts the vascular basement membrane with its
abluminal surface, whereas the pericyte sheath is embedded in this
basement membrane. In some cases pericytes may also establish
interactions with endothelial cells via extended processes (not
shown). The diagram also shows PMNs at different stages of
migration. The boxed areas (A and B) in the top diagram are
displayed at higher magnification in the corresponding bottom
panels. PMN = Polymorphonuclear neutrophil; EC = endothe-
lial cell; BM = Basement membrane; PC = Pericyte; TEM =
Trans-endothelial migration; TBMM = Trans-basement mem-
brane migration; TPM = Trans-pericyte migration. Box A shows
a transmigrating PMN that has broken through the endothelium
but is separated from the pericyte sheath by the vascular BM. In
this situation, pericytes still maintain most of their actin bundles
and focal adhesions which support the binding of pericytes to the
BM. Diffusible inflammatory mediators (e.g. nitric oxide or
complement C3a/5a) may relax pericytes to a certain extent,
but this is not indicated in the diagram. At the stage shown in box
B, the transmigrating PMN has penetrated the BM and
established direct contacts with the pericyte sheath. Direct
engagement with the migrating PMN elicits signals to induce
pericyte relaxation disassembling actin stress fibers. Relaxation of
pericytes expands the gaps between them and thins (or opens) the
BM at LERs which align with pericyte gaps, thereby facilitating
PMN transmigration.
(TIF)
Movie S1 Response of pericytes to DMSO-treated
PMNs. Mouse retinal primary pericytes were seeded on the
FN-coated glass surface of culture dishes for 4 hours to allow cell
spreading. Cells were imaged in time-lapse at 37uC for 1 hour
using the setting for phase contrast and then washed DMSO-
treated PMNs were added. Interaction of pericytes and PMNs
were further recorded for 2 hours after adding PMNs.
(AVI)
Movie S2 Response of pericytes to PMA-treated PMNs.
Mouse retinal primary pericytes were seeded on the FN-coated
glass surface of culture dishes for 4 hours to allow cell spreading.
Cells were imaged in time-lapse at 37uC for 1 hour using the
setting for phase contrast and then washed PMA-treated PMNs
were added. Interaction of pericytes and PMNs were further
recorded for 2 hours after adding PMNs.
(AVI)
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